Danish Pharmaceuticals & Biotech Mid-Large Cap Stocks

H. Lundbeck

Market Cap: DKK 42.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Novo Nordisk

Market Cap: DKK 1.2t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Genmab

Market Cap: DKK 94.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Bavarian Nordic

Market Cap: DKK 14.0b

Develops, manufactures, and supplies life-saving vaccines.

ALK-Abelló

Market Cap: DKK 57.9b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

Zealand Pharma

Market Cap: DKK 21.4b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.